Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 1928

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.10, p 0.802). This receipt's hash covers every field on it, plus the hash of receipt 1927, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 1928
    18 Oct 2026, 09:51 UTC

    EMC2

    dopamine neurons, braak

    predictionEMC2 in dopamine neurons tracks Braak Lewy-body stage

    registereddf0924e8b4dea875

    discovery+0.10 p=0.802 n=9

    replication-0.15 p=0.699 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.10, p 0.802)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    df6109610ef7564ea84d6ee8…
    follows 70d138ba1632…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 1928: EMC2 in dopamine neurons, braak

power
full sample -0.03 (p 0.908, n 18), 95% CI -0.49 to +0.44. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.03 (p 0.922, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.08 (p 0.748, n 18). could be the mix.
skeptic
leave-one-out range -0.14 to +0.13, sign flips 7; without severely affected donors -0.03 (p 0.908, n 18). fragile.
cell type
strongest in microglia: +0.62 (p 0.0062, n 18) vs -0.03 in dopamine neurons. proposing microglia.
axis
no measure beats "tracks Braak Lewy-body stage" for EMC2 in dopamine neurons.

follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up EMC2 · microglia · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.23 p 0.424 (needs p < 7.9e-4)